https://www.selleckchem.com/pr....oducts/1-methyl-3-ni
Advanced light-chain (AL) amyloidosis is associated with poor prognosis, with a 5-year survival rate of 25%. Prognostication is based on the revised Mayo (rMayo) staging according to serum cardiac biomarkers. This study sought to determine whether global longitudinal strain (GLS) can provide incremental prognostic value in patients with advanced disease. Baseline (pre-treatment) clinical, 2-dimensional echocardiogram with GLS and laboratory data were collected prospectively in 94 patients with newly diagn
Like
Comment
Share
